Inogen, Inc. (Nasdaq: INGN), a leading medical technology company, has announced the appointment of Jason Richardson as its new Chief Financial Officer (CFO), effective April 6, 2026. This strategic move comes as part of the company's efforts to enhance its leadership team and drive growth in the respiratory products market. Richardson, who previously served as CFO at Baxter International Inc., brings a wealth of experience in finance and operations within the healthcare sector. His appointment follows the decision of Michael Bourque to step down from the CFO role, although he will remain with Inogen as a Senior Advisor until June 30, 2026, to ensure a smooth transition. The company has also approved an employment agreement for Richardson, which includes a base salary of $525,000, a target annual performance bonus of 70% of his salary, and equity awards comprising 200,000 shares in restricted stock units. This leadership change is expected to positively impact Inogen's operational execution and strategic outlook, as the company aims to capture significant market opportunities in the coming years.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.